NORTH CHICAGO, Ill.,
Jan. 6, 2021 /PRNewswire/ -- AbbVie
(NYSE: ABBV) will participate in the 39th Annual J.P.
Morgan Healthcare Conference on Tuesday,
January 12, 2021. Members of AbbVie's executive leadership
team will present virtually at 3:30 p.m.
Central time, including Richard A.
Gonzalez, chairman of the board and chief executive officer,
Michael Severino, M.D., vice
chairman and president, Robert A.
Michael, executive vice president and chief financial
officer, and Jeffrey R. Stewart,
executive vice president, commercial operations.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
AbbVie's mission is to discover and deliver innovative medicines
that solve serious health issues today and address the medical
challenges of tomorrow. We strive to have a remarkable impact on
people's lives across several key therapeutic areas: immunology,
oncology, neuroscience, eye care, virology, women's health and
gastroenterology, in addition to products and services across its
Allergan Aesthetics portfolio. For more information about AbbVie,
please visit us at www.abbvie.com. Follow @abbvie on
Twitter, Facebook, Instagram, YouTube and LinkedIn.